COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
349
|
0 |
VPS51 |
Q9UID3
|
VPS51 subunit of GARP complex
|
|
1.1E-08 |
0.452 |
0.846 |
292
|
0 |
MIR150 |
|
microRNA 150
|
|
|
0.455 |
0.808 |
282
|
0 |
PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
246
|
0 |
TM7SF2 |
O76062
|
transmembrane 7 superfamily member 2
|
Enzyme
|
1.4E-07 |
0.486 |
0.808 |
217
|
0 |
PSG2 |
P11465
|
pregnancy specific beta-1-glycoprotein 2
|
|
1.4E-30 |
0.492 |
0.731 |
210
|
0 |
CEACAM7 |
Q14002
|
CEA cell adhesion molecule 7
|
|
1.3E-07 |
0.494 |
0.769 |
202
|
0 |
MIR320A |
|
microRNA 320a
|
|
|
0.526 |
0.808 |
145
|
0 |
OR10A4 |
Q9H209
|
olfactory receptor family 10 subfamily A member 4
|
G-protein coupled receptor
|
1.7E-05 |
0.540 |
0.808 |
128
|
0 |
LGALS3BP |
Q08380
|
galectin 3 binding protein
|
|
2.7E-07 |
0.546 |
0.769 |
127
|
0 |
MIR30C2 |
|
microRNA 30c-2
|
|
|
0.546 |
0.769 |
115
|
0 |
MIR136 |
|
microRNA 136
|
|
|
0.584 |
0.731 |
79
|
0 |
SAGE1 |
Q9NXZ1
|
sarcoma antigen 1
|
Enzyme
|
8.6E-18 |
0.588 |
0.654 |
78
|
0 |
MIR532 |
|
microRNA 532
|
|
|
0.628 |
0.615 |
52
|
0 |
ATD |
|
asphixiating thoracic dystrophy (chondroectodermal dysplasia-like syndrome)
|
|
|
0.656 |
0.731 |
36
|
0 |
EAF2 |
Q96CJ1
|
ELL associated factor 2
|
|
2.2E-07 |
0.695 |
0.538 |
35
|
0 |
POU3F1 |
Q03052
|
POU class 3 homeobox 1
|
|
0.56 |
0.711 |
0.462 |
25
|
0 |
RPL23 |
P62829
|
ribosomal protein L23
|
Nucleic acid binding
|
0.33 |
0.729 |
0.500 |
24
|
0 |
TMBIM4 |
Q9HC24
|
transmembrane BAX inhibitor motif containing 4
|
|
3.9E-06 |
0.743 |
0.500 |
21
|
0 |
DURS1 |
|
Duane retraction syndrome 1
|
|
|
0.839 |
0.154 |
8
|
0 |
FHDC1 |
Q9C0D6
|
FH2 domain containing 1
|
|
6.3E-05 |
0.839 |
0.231 |
6
|
0 |
C20orf181 |
|
chromosome 20 open reading frame 181
|
|
|
0.479 |
0.885 |
246
|
1 |
TRIM21 |
P19474
|
tripartite motif containing 21
|
|
3.4E-09 |
0.485 |
0.808 |
229
|
1 |
HIRA |
P54198
|
histone cell cycle regulator
|
Nucleic acid binding
|
1.00 |
0.537 |
0.808 |
157
|
1 |